Status:

RECRUITING

Vista Protein Expression of Monocyte and T Cell Subsets in Multiple Sclerosis and Its Clinical Correlation

Lead Sponsor:

Koç University

Conditions:

Multiple Sclerosis, MS

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this study is to investigate whether VISTA, a newly identified negative immune regulatory protein, differs in monocytes and T cells of patients diagnosed with Multiple Sclerosis (MS) and Cl...

Eligibility Criteria

Inclusion

  • Patients aged 18 years or older diagnosed with MS or CIS according to the 2017 McDonald criteria.
  • No diagnosis of any autoimmune disease or malignancy.
  • No new diagnosis of autoimmune disease or malignancy during the 1-year follow-up period.
  • No use of antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), or steroid treatments within one month prior to blood sampling.
  • No vaccination within one month prior to blood sampling.
  • Not in the menstrual cycle at the time of blood sampling.

Exclusion

  • Age below 18 years.
  • Presence of a previous or newly diagnosed autoimmune disease or malignancy at the time of blood sampling.
  • Use of antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), or steroid treatments within one month prior to blood sampling.
  • Vaccination within one month prior to blood sampling
  • Being in the menstrual cycle at the time of blood sampling
  • Patients without a definitive MS diagnosis according to the 2017 McDonald criteria will not be included in the study.

Key Trial Info

Start Date :

June 30 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 30 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06957145

Start Date

June 30 2025

End Date

December 30 2026

Last Update

September 3 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Koc University

Istanbul, Istanbul, Turkey (Türkiye)

2

Bakirkoy Prof. Dr. Mazhar Osman Training and Research Hospital for Psychiatric, Neurologic and Neurosurgical Diseases, University of Health Sciences, Istanbul, Turkey

Istanbul, Turkey (Türkiye)